NRX Pharmaceuticals, Inc. Deferred Tax Assets, Operating Loss Carryforwards
NRX Pharmaceuticals, Inc. (NRXP) had Deferred Tax Assets, Operating Loss Carryforwards of $44.41 million as of 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-23
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $44.41M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $39.75M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $35.86M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $33.64M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $44.41M 10-K · filed 2026-03-23 | |
| 2024-12-31 | $39.75M 10-K · filed 2026-03-23 | |
| 2023-12-31 | $35.86M 10-K · filed 2025-03-14 | |
| 2022-12-31 | $33.64M 10-K · filed 2024-03-29 | |
| 2021-12-31 | $28.05M 10-K · filed 2023-03-31 | |
| 2020-12-31 | $8.24M 10-K · filed 2022-03-31 | $105.56K 10-K · filed 2021-04-01 |
| 2019-12-31 | $0.00 10-K/A · filed 2021-05-14 | |
| 2018-12-31 | $21.06K 10-K · filed 2020-03-30 | |
| 2017-12-31 | $21.06K 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |